Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from OptimizeRx

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022

Upgrades

Benzinga

OptimizeRx: Q4 Earnings Insights

OptimizeRx (NASDAQ:OPRX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings OptimizeRx beat estimated earnings by 10.0%, reporting an EPS of $0.22 versus an estimate of $0.2.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.